March 14, 2019
BioLineRx to Present at the 29th Annual Oppenheimer Healthcare Conference
February 7, 2019
BioLineRx Announces Closing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants
February 5, 2019
BioLineRx Announces Pricing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants
February 4, 2019
BioLineRx Announces Proposed Underwritten Public Offering of its American Depositary Shares and Warrants